At a glance
- Originator Menarini
- Class Cyclic peptides; Oligopeptides
- Mechanism of Action Neurokinin 2 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma; Cystitis; Irritable bowel syndrome
Most Recent Events
- 02 Mar 2001 Discontinued-Preclinical for Asthma in Italy (Unknown route)
- 02 Mar 2001 Discontinued-Preclinical for Cystitis in Italy (Unknown route)
- 02 Mar 2001 Discontinued-Preclinical for Irritable bowel syndrome in Italy (Unknown route)